We are live on ! Find out more
BLCM

Bellicum Pharmaceuticals, Inc.
BLCM

Delisted

BLCM was delisted on the 1st of June, 2023.

Back to rankings

29 hedge funds and large institutions have $5.14M invested in Bellicum Pharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

11% less capital invested

Capital invested by funds: $5.76M → $5.14M (-$612K)

15% less funds holding

Funds holding: 34 → 29 (-5)

45% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 11

Holders
29
Holders Change
-5
Holders Change %
-14.71%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
3
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$142K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$139K
3
Citadel Advisors
Citadel Advisors
Florida
+$118K
4
LPL Financial
LPL Financial
California
+$72.6K
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$57.8K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$563K
2
AFM
Anson Funds Management
Texas
-$350K
3
GCP
GSA Capital Partners
United Kingdom
-$235K
4
Renaissance Technologies
Renaissance Technologies
New York
-$94K
5
Millennium Management
Millennium Management
New York
-$57K
Name Holding Trade Value Shares
Change 		Change in
Stake
GCP
26
GSA Capital Partners
United Kingdom
– -$235K -66,558 Closed
Renaissance Technologies
27
Renaissance Technologies
New York
– -$94K -26,631 Closed
Millennium Management
28
Millennium Management
New York
– -$57K -16,248 Closed
Qube Research & Technologies (QRT)
29
Qube Research & Technologies (QRT)
United Kingdom
– -$56K -15,760 Closed
TRCT
30
Tower Research Capital (TRC)
New York
– -$15K -4,336 Closed
AF
31
Allworth Financial
California
– -$1K -300 Closed
NSIM
32
North Star Investment Management
Illinois
– +$4 +1 New
Bank of America
33
Bank of America
North Carolina
– +$113 +26 New
1
2

BLCM Hedge Fund Activity: Q1 2021 in Review

29 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Bellicum Pharmaceuticals, Inc. (BLCM) for Q1 2021, worth a combined $5.14M — down 11% from $5.76M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of BLCM and 6 opened new positions — a net loss of 5 holders — while 3 trimmed existing stakes and 5 added.

The largest buyer was Acadian Asset Management, opening a new position worth an estimated $142K. The largest seller was Sabby Management, exiting entirely with an estimated $563K sold.

  • 29 institutional investors held Bellicum Pharmaceuticals, Inc. (BLCM) as of Q1 2021, down from 34 in Q4 2020.
  • Funds reported $5.14M of Bellicum Pharmaceuticals, Inc. stock for Q1 2021, down 11% quarter-over-quarter.
  • 6 funds opened new Bellicum Pharmaceuticals, Inc. positions in Q1 2021 and 11 closed out, a net change of -5 holders.
  • The largest Bellicum Pharmaceuticals, Inc. buyer in Q1 2021 was Acadian Asset Management, an estimated $142K added.
  • The largest Bellicum Pharmaceuticals, Inc. seller in Q1 2021 was Sabby Management, an estimated $563K sold.

Based on aggregated 13F filings for Q1 2021.